TRERF1 and cancer: As shown in Figure 7A, the pre-treatments with RAPA/Honokiol increased splenocyte-mediated killing of RENCA cells compared with control; however, when the cancer cells were pre-treated with RAPA + Honokiol combination, it significantly increased splenocyte-mediated killing.